Form 4: Amgen SVP Rachna Khosla Reports Stock Disposal to Cover Tax Obligations

Rachna Khosla, SVP of Business Development at Amgen, disposed of 438 shares of common stock on March 18, 2024, to cover tax obligations related to vested Restricted Stock Units (RSUs).

Summary

• On March 18, 2024, Rachna Khosla, Senior Vice President of Business Development at Amgen Inc., disposed of 438 shares of Amgen common stock.
• The transaction was executed to satisfy tax withholding obligations related to the vesting of Restricted Stock Units (RSUs).
• The shares were disposed of at a price of $268.87 per share.
• Following the transaction, Khosla directly owns 8,190 shares of Amgen common stock, which includes unvested RSUs and dividend equivalents.
• The RSUs vest in installments over several dates, with the final vesting date being May 2, 2027.

Sentiment

Score: 5

Explanation: This is a neutral filing related to standard insider trading practices for tax obligations; it doesn't inherently indicate positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors. This filing indicates that an executive disposed of shares to cover tax obligations, which is a common practice.

Comparison to Industry Standards

• Form 4 filings are standard practice across all publicly listed companies in the US, as mandated by the Securities and Exchange Commission (SEC).
• Companies like Johnson & Johnson (JNJ), Pfizer (PFE), and Merck (MRK) also have frequent Form 4 filings related to their executives' stock transactions.
• The disposal of shares to cover tax obligations is a common occurrence among executives receiving equity compensation, aligning with industry norms.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on shareholders, as it is a routine disposal of shares for tax purposes.

Key Dates